Literature DB >> 28509174

De novo papillary carcinoma in a renal allograft: the pros and cons of immunosuppression.

Rachelle Asciak1, Jesmar Buttigieg2, Louis Buhagiar2.   

Abstract

We present a case of a multifocal kidney transplant renal cell carcinoma in a 35-year-old lady, presenting 16 years after kidney transplantation, diagnosed during investigation of recurrent urinary tract infections. The patient underwent a graft nephrectomy and subsequently maintained on haemodialysis. She remained disease-free after 4 years of surveillance and thus reactivated on the transplant list. This case reinforces the fact that immunosuppressive therapy has made kidney transplantation possible; however, it is accompanied by a higher incidence of malignancy. It also reinforces the importance of lifelong screening of both native and renal transplant grafts.

Entities:  

Keywords:  Allograft malignancy; Allograft nephrectomy; Immunosuppression; Kidney transplant

Year:  2015        PMID: 28509174      PMCID: PMC5411666          DOI: 10.1007/s13730-015-0202-1

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  30 in total

1.  Incidence of malignant neoplasia after heart transplantation--a comparison between cyclosporine a and tacrolimus.

Authors:  Uwe Fuchs; Sarah Klein; Armin Zittermann; Stephan M Ensminger; Uwe Schulz; Jan F Gummert
Journal:  Ann Transplant       Date:  2014-06-23       Impact factor: 1.530

2.  Renal cell carcinoma in the native and allograft kidneys of renal transplant recipients.

Authors:  Michael Leveridge; Mireia Musquera; Andrew Evans; Carl Cardella; York Pei; Michael Jewett; Michael Robinette; Antonio Finelli
Journal:  J Urol       Date:  2011-05-14       Impact factor: 7.450

3.  Renal cell carcinoma in patients with end-stage renal disease is associated with more favourable histological features and prognosis.

Authors:  Kenneth Chen; Hong Hong Huang; Hakan Aydin; Yeh Hong Tan; Weber K O Lau; Christopher W S Cheng; John S P Yuen
Journal:  Scand J Urol       Date:  2015-03-17       Impact factor: 1.612

4.  Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population.

Authors:  Yann Neuzillet; Xavier Tillou; Romain Mathieu; Jean-Alexandre Long; Marc Gigante; Philippe Paparel; Laura Poissonnier; Hervé Baumert; Bernard Escudier; Hervé Lang; Nathalie Rioux-Leclercq; Pierre Bigot; Jean-Christophe Bernhard; Laurence Albiges; Laurence Bastien; Jacques Petit; Fabien Saint; Franck Bruyere; Jean-Michel Boutin; Nicolas Brichart; Georges Karam; Julien Branchereau; Jean-Marie Ferriere; Hervé Wallerand; Sébastien Barbet; Hicham Elkentaoui; Jacques Hubert; Benoit Feuillu; Pierre-Etienne Theveniaud; Arnauld Villers; Laurent Zini; Aurélien Descazeaux; Morgan Roupret; Benoit Barrou; Karim Fehri; Thierry Lebret; Jacques Tostain; Jean-Etienne Terrier; Nicolas Terrier; Lucille Martin; Fabrice Dugardin; Ismaël Galliot; Frédéric Staerman; Marie-Dominique Azemar; Jacques Irani; Baptiste Tisserand; Marc-Olivier Timsit; Federico Sallusto; Pascal Rischmann; Laurent Guy; Antoine Valeri; Charles Deruelle; Abdel-Rahmène Azzouzi; Denis Chautard; Arnaud Mejean; Laurent Salomon; Jérôme Rigaud; Christian Pfister; Michel Soulié; François Kleinclauss; Lionel Badet; Jean-Jacques Patard
Journal:  Eur Urol       Date:  2011-03-02       Impact factor: 20.096

5.  Where are the limits of elective nephron- sparing surgery in renal cell carcinoma?

Authors:  A Schlichter; H Wunderlich; K Junker; H Kosmehl; D H Zermann; J Schubert
Journal:  Eur Urol       Date:  2000-05       Impact factor: 20.096

6.  Cancer risk with alemtuzumab following kidney transplantation.

Authors:  C Puttarajappa; J Yabes; L Bei; N Shah; J Bernardo; J McCauley; A Basu; H Tan; R Shapiro; M Unruh; C Wu
Journal:  Clin Transplant       Date:  2013-03-11       Impact factor: 2.863

Review 7.  Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy.

Authors:  David S Dimarco; Christine M Lohse; Horst Zincke; John C Cheville; Michael L Blute
Journal:  Urology       Date:  2004-09       Impact factor: 2.649

8.  Renal cell carcinoma from a transplanted allograft: two case reports and a review of the literature.

Authors:  Wassim McHayleh; John P Morcos; Tong Wu; Ron Shapiro; Samuel Yousem; Leonard Appleman; David M Friedland
Journal:  Clin Genitourin Cancer       Date:  2008-03       Impact factor: 2.872

9.  The pattern of excess cancer in dialysis and transplantation.

Authors:  John H Stewart; Claire M Vajdic; Marina T van Leeuwen; Janaki Amin; Angela C Webster; Jeremy R Chapman; Stephen P McDonald; Andrew E Grulich; Margaret R E McCredie
Journal:  Nephrol Dial Transplant       Date:  2009-07-08       Impact factor: 5.992

10.  Multifocal renal cell carcinoma: clinicopathologic features and outcomes for tumors </=4 cm.

Authors:  Paul L Crispen; Christine M Lohse; Michael L Blute
Journal:  Adv Urol       Date:  2008
View more
  1 in total

1.  Successful partial nephrectomy of a T1b multilocular clear cell renal cell carcinoma arising in a renal graft.

Authors:  Florin Ioan Elec; Andreea Zaharie; Gheorghiţă Iacob; Tudor Moisoiu; Dan Burghelea; Mihai Adrian Socaciu; Radu Ion Badea; Liviu Ghervan
Journal:  Urol Case Rep       Date:  2018-10-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.